Revvity PE ratio RVTY

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: 75.6×
10-year median: 34.8×
Against its 10-year history: 93rd; percentile: 0 is its lowest day, 100 its highest
10-year range: 13.6× to 102×
Peer median: 39.3×

Revvity's PE ratio is 75.6× as of Oct 23, 2026: a share price of $158.77 against $2.10 of earnings per share over the last twelve months.

That is above its ten-year median of 34.8×, higher than on 93% of days in the last ten years.

Over that time it ranged from 13.6× in Nov 2023 to 102× in Aug 2024.

The median for 10 diagnostics and research stocks of a similar size is 39.3×.

PE ratio over time

median 34.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	75.6×	40.3×	75.6×
2025	48.6×	35.1×	60.9×
2024	54.1×	17.5×	102×
2023	18.6×	13.6×	30.5×
2022	28.1×	16.9×	29.1×
2021	20.0×	14.6×	43.4×
2020	39.0×	34.8×	59.1×
2019	46.2×	35.6×	83.9×
2018	69.0×	20.2×	77.8×
2017	20.3×	19.2×	33.9×
2016	24.3×	23.2×	32.0×
2015	34.8×	25.5×	38.1×
2014	25.9×	23.7×	58.6×
2013	54.9×	45.4×	59.4×
2012	447×	390×	461×

Against its peers

Companies in Medical - Diagnostics & Research nearest Revvity's size, closest first, today.

Company	PE ratio
RVTYRevvity	75.6×
MEDPMedpace	39.2×
LHLabcorp	27.2×
DGXQuest Diagnostics	25.7×
BIOBio-Rad Laboratories	44.8×
MTDMettler-Toledo International	37.6×
CAICaris Life Sciences	86.5×
ILMNIllumina	50.1×
IDXXIDEXX Laboratories	39.4×
WATWaters	113×
IQVIQVIA	34.7×
Peer median	39.3×

Where Revvity ranks

#15of 20Diagnostics and research stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Revvity

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.